Symbol
FDMT on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
2.95M shares
Security Ownership
6.4%

Venrock Healthcare Capital Partners III, L.P. ownership in 4D Molecular Therapeutics, Inc. Common Stock (FDMT)

2025-02-14 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.95M shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT). This represents 6.4% percent ownership of the company.